Efficacy of the anti-edema drug L-lysine aescinat in stroke

Gafurov B.G.

doi:https://doi.org/

Gafurov B.G.

Otdelenie ékstrennoĭ nevrologii Respublikanskogo nauchnogo tsentra ékstrennoĭ meditsinskoĭ pomoshchi, otdelenie neĭroreabilitatsii Respublikanskogo nauchnogo tsentra neĭrokhirurgii, Tashkent, Respublika Uzbekistan

Efficacy of the anti-edema drug L-lysine aescinat in stroke

Authors:

Gafurov B.G.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(12‑2): 31‑34

Read: 29313 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Gafurov BG. Efficacy of the anti-edema drug L-lysine aescinat in stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(12‑2):31‑34. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Sequential use of botulinum toxin A and bovhyaluronidase azoximer in the correction of post-stroke spasticity. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):80-85

Central nervous system involvement in systemic lupus erythematosus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):124-129

Resolution of the Council of Experts on the Treatment of Radiculopathy “New approaches to the treatment of back pain”. Russian Journal of Pain. 2025;(1):84-90

Adjuvant pharmacological modulation with Cytoflavin in rehabilitation at stages 2—3 in patients with acute cerebral insufficiency and post-intensive care syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):78-85

Anesthetic management of endovascular procedures in patients with ischemic stroke. Russian Journal of Anesthesiology and Reanimatology. 2025;(2):20-25

Comparison of fluoroscopy and intracardiac echocardiography for control of endovascular closure of patent foramen ovale. Russian Cardiology Bulletin. 2025;(1):64-69

Mathematical modeling of outcomes in patients with clinical combination of ischemic stroke and COVID-19 complicated by multiple organ failure. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):42-49

Socio-economic damage caused by elevated low-density lipoprotein cholesterol levels. Medical Technologies. Assessment and Choice. 2025;(2):88-98

Cerebrolysin with reperfusion therapy in ischemic stroke: a prospective analysis of multimodal brain imaging data from the CEREHETIS trial. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):84-98

Prediction of mortality in severe ischemic stroke during COVID-19 in patients with multiorgan dysfunction. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):120-127

Abstract:

Forty-nine patients with ischemic hemispheric stroke admitted within 48 hours of stroke onset were studied. Twenty-nine patients (the main group) received L-lysine aescinat as an anti-edema drug. The efficacy was evaluated clinically and by EEG and autonomic testing. The rapid recovery of wakefulness and reduction in neurological deficit as well as the improvement of brain electrical activity and autonomic functions were observed. L-lysine aescinat can be recommended to control the syndrome of intracranial hypertension in stroke.

Keywords:

ischemic stroke

syndrome of intracranial hypertension

L-lysine aescinat

Authors:

Gafurov B.G.

Close metadata